Ted Gooley

2.7k total citations
42 papers, 1.7k citations indexed

About

Ted Gooley is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Ted Gooley has authored 42 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 13 papers in Immunology and 9 papers in Oncology. Recurrent topics in Ted Gooley's work include Hematopoietic Stem Cell Transplantation (20 papers), Acute Lymphoblastic Leukemia research (8 papers) and T-cell and B-cell Immunology (7 papers). Ted Gooley is often cited by papers focused on Hematopoietic Stem Cell Transplantation (20 papers), Acute Lymphoblastic Leukemia research (8 papers) and T-cell and B-cell Immunology (7 papers). Ted Gooley collaborates with scholars based in United States, South Africa and Australia. Ted Gooley's co-authors include Paul J. Martin, Effie W. Petersdorf, Mari Malkki, Jerald P. Radich, Claudio Anasetti, John A. Hansen, Frederick R. Appelbaum, Anajane G. Smith, Eric Mickelson and Ann E. Woolfrey and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Ted Gooley

37 papers receiving 1.7k citations

Peers

Countries citing papers authored by Ted Gooley

Since Specialization

Citations

This map shows the geographic impact of Ted Gooley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ted Gooley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ted Gooley more than expected).

Fields of papers citing papers by Ted Gooley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ted Gooley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ted Gooley. The network helps show where Ted Gooley may publish in the future.

Co-authorship network of co-authors of Ted Gooley

This figure shows the co-authorship network connecting the top 25 collaborators of Ted Gooley. A scholar is included among the top collaborators of Ted Gooley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ted Gooley. Ted Gooley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Novel R Shiny Tool TVCurveTM for Survival Analysis with Time-Varying Covariate in Oncology Clinical Studies: Overcoming Biases and Enhancing Collaboration 2025 ·Transplantation and Cellular Therapy ·Yimei Li, Yang Qiao, (unknown), Jordan Gauthier, Qiang Zhang, Jenna Voutsinas, Wendy M. Leisenring, Ted Gooley, Corinne Summers, Alexandre V. Hirayama, Cameron J. Turtle, Rebecca Gardner, Jarcy Zee, Qian Wu	0
2	Long-term outcomes and quality of life with treosulfan-based conditioning in hematological malignancies 2025 ·Blood Advances ·Rohtesh S. Mehta, Stephanie J. Lee, Ted Gooley, (unknown), Ann Dahlberg, Colleen Delaney, Boglarka Gyurkocza, (unknown), H. Joachim Deeg, Filippo Milano	0
3	RGI-2001 for the prophylaxis of acute graft-versus-host disease after allogeneic HCT 2025 ·Blood ·Zachariah DeFilipp, Hannah Choe, Yvonne A. Efebera, Ayman Saad, (unknown), Lazaros J. Lekakis, Jean A. Yared, Gary J. Schiller, Markus Y. Mapara, Amer Assal, Ted Gooley, Jack D. Bui, (unknown), (unknown), Yi‐Bin Chen	1
4	Osimertinib retreatment for patients with advanced EGFR-mutated non-small cell lung cancer 2025 ·Cancer Treatment and Research Communications ·Kevin M. Levine, (unknown), Ted Gooley, Jenna Voutsinas, (unknown), Keith D. Eaton, Rafael Santana-Dávila, Alice H. Berger, Christina S. Baik	0
5	Defining pathogenic IL-17 and CSF-1 gene expression signatures in chronic graft-versus-host disease 2025 ·Blood ·(unknown), Kathleen S. Ensbey, (unknown), Isaac Jenkins, (unknown), Kelli P. A. MacDonald, Bruce R. Blazar, (unknown), Ted Gooley, Simone A. Minnie, Stephanie J. Lee, Scott N. Furlan, Geoffrey R. Hill	4
6	Abstract A003: Preliminary safety results from a phase I study of autologous transgenic T cells expressing high affinity mesothelin-specific T cell receptor (TCR) (FH-TCR TMSLN) in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDA) 2024 ·Cancer Research ·E. Gabriela Chiorean, Aude G. Chapuis, Andrew L. Coveler, Cecilia C.S. Yeung, Ted Gooley, David B. Zhen, Gentry Teng King, Stacey A. Cohen, Lindsay M. Hannan, Rachael A. Safyan, (unknown), (unknown), (unknown), Thomas M. Schmitt, Philip D. Greenberg	0
7	Craniospinal irradiation for CNS leukemia: rates of response and durability of CNS control 2024 ·Journal of Neuro-Oncology ·Maryam Ebadi, (unknown), Ted Gooley, Ralph P. Ermoian, Lia M. Halasz, Simon S. Lo, Jonathan T. Yang, (unknown), (unknown), Ryan D. Cassaday, Jerome Graber, Lynne P. Taylor, Vyshak Alva Venur, Yolanda D. Tseng	4
8	Impact of GVHD prophylaxis on CMV reactivation and disease after HLA-matched peripheral blood stem cell transplantation 2023 ·Blood Advances ·Masumi Ueda, Hu Xie, Danniel Zamora, Mary E.D. Flowers, Geoffrey R. Hill, Marco Mielcarek, Brenda M. Sandmaier, Ted Gooley, Michael Boeckh	12
9	EASIX-1year and late mortality after allogeneic stem cell transplantation 2023 ·Blood Advances ·Lambros Kordelas, Tobias Terzer, Ted Gooley, Chris Davis, Brenda M. Sandmaier, Mohamed L. Sorror, Olaf Penack, (unknown), Igor Wolfgang Blau, Dietrich W. Beelen, Aleksandar Radujkovic, Peter Dreger, Thomas Luft	15
10	1,5-Anhydroglucitol and Neonatal Complications in Pregnancy Complicated by Diabetes 2015 ·Endocrine Practice ·Lorena Wright, Irl B. Hirsch, Ted Gooley, Zane A. Brown	15
11	Extracorporeal photopheresis combined with pentostatin in the conditioning regimen for canine hematopoietic cell transplantation does not prevent GVHD 2014 ·Bone Marrow Transplantation ·Wolfgang Bethge, Fábio R. Kerbauy, Erlinda B. Santos, Ted Gooley, R Storb, Brenda M. Sandmaier	6
12	Prevention of Dimethylsulfoxide-Related Nausea and Vomiting by Prophylactic Administration of Ondansetron for Patients Receiving Autologous Cryopreserved Peripheral Blood Stem Cells 2013 ·Oncology nursing forum ·Seth Eisenberg, (unknown), Michael Linenberger, Ted Gooley, Leona Holmberg	8
13	Significant differences in outcome following unrelated donor HCT can be better predicted using an algorithm incorporating both allele and epitope level matching for HLA-DPB1 2009 ·UCL Discovery (University College London) ·(unknown), Katharina Fleischhauer, E. Zino, Mari Malkki, (unknown), Y Morishima, Ted Gooley, E.W. Petersdorf	1
14	Clinical importance of HLA‐DPB1 in haematopoietic cell transplantation 2007 ·Tissue Antigens ·Bronwen E. Shaw, Ted Gooley, J. Alejandro Madrigal, Mari Malkki, Steven G. E. Marsh, Effie W. Petersdorf	16
15	The biological significance of HLA‐DP gene variation in haematopoietic cell transplantation 2001 ·British Journal of Haematology ·Effie W. Petersdorf, Ted Gooley, Mari Malkki, Claudio Anasetti, Paul J. Martin, Ann E. Woolfrey, Anajane G. Smith, Eric Mickelson, John A. Hansen	108
16	Cutting Edge: Persistent Fetal Microchimerism in T Lymphocytes Is Associated with HLA-DQA10501: Implications in Autoimmunity 2000 ·The Journal of Immunology* ·Nathalie Lambert, Paul C. Evans, (unknown), Sean Maloney, Ted Gooley, D E Furst, J. Lee Nelson	102
17	Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors. 1996 ·Journal of Clinical Oncology ·Jeanne E. Anderson, F R Appelbaum, Gary Schoch, Ted Gooley, Claudio Anasetti, Jack W. Singer, Eileen Bryant, CD Buckner, Thomas R. Chauncey, R A Clift	88
18	Unrelated donor marrow transplantation for myelodysplasia (MDS) and MDS‐related acute myeloid leukaemia 1996 ·British Journal of Haematology ·Jeanne E. Anderson, (unknown), Frederick R. Appelbaum, Gary Schoch, Ted Gooley, John A. Hansen, C. Dean Buckner, (unknown), Keith Sullivan, R Storb	95
19	Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas 1995 ·The Lancet ·Oliver W. Press, F. R. Appelbaum, Paul J. Martin, Dana C. Matthews, Irwin D. Bernstein, Janet F. Eary, W. B. Nelp, Ted Gooley, S. Glenn, Bruce A. Porter, D.R Fisher	352
20	PREDICTION OF CYTOMEGALOVIRUS PNEUMONIA AFTER MARROW TRANSPLANTATION FROM CELLULAR CHARACTERISTICS AND CYTOMEGALOVIRUS CULTURE OF BRONCHOALVEOLAR LAVAGE FLUID 1994 ·Transplantation ·Monica A. Slavin, Ted Gooley, Raleigh A. Bowden	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact